PHARMACOLOGY OF BIOTECHNOLOGICAL PRODUCTS

knowledge of the differences between traditional and biotechnological drugs; 

knowledge of the therapeutic use of medicines; knowledge of gene therapies; 

Ability to interpret scientific results in the research of biotechnological drugs.

Required prerequisites: none
Attendance of lessons: compulsory

Exam test: no ongoing tests; no end-of-course test; 
Exam dates: see calendar

Delivery of teaching material: handouts / slides
Information for students with disabilities and / or SLD To guarantee equal opportunities and in compliance with the laws in force, interested students can ask for a personal interview in order to plan any compensatory and / or dispensatory measures, based on the didactic objectives and specific needs. It is also possible to contact the CInAP contact person (Center for Active and Participatory Integration - Services for Disabilities and / or SLD) of the Department of Biomedical and Biotechnological Sciences.

 • Biotechnological drugs in oncology

. Biotechnological drugs for metabolic diseases 

• Biotechnological  drugs in ophthalmology

• Biotechnological drugs in dermatology

• Biotechnological drugs in neurology

• Biotechnological  drugs for the cardiovascular system

Calabrese, Molteni, Racagni "Farmaci Biotecnologici e Terapie Avanzate" Ed EDRA

. Goodman and Gilman - Le basi farmacologiche della terapia. Ed. Zanichelli 13^ ed.

·      Rossi, Cuomo, Riccardi - Farmacologia. Principi di base e applicazioni terapeutiche. Ed. Minerva Medica, 4^ ed.

Biological drugs in oncology:
e. g.monoclonal antibodies,
· Biological drugs in ophthalmology: eg. anti-VEGF drugs
Biological drugs in dermatology: eg. monoclonal antibodies, fusion proteins
· Biological drugs in neurology: eg. interferon-beta; natalizumab
· Biological drugs for the cardiovascular system: e.g. PCSK9i